Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uday Popat

Showing results (81-90 of 262) with videos related to

Pageof 27
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of TreatmentManuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Blood|June 21, 2008
The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasmsConstantine S Tam, Roberto M Nussenzveig, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
American Journal of Hematology|April 23, 2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphomaChitra Hosing, Rima M Saliba, Sheena Ahlawat, et al.
American Journal of Hematology|July 1, 2020
Haploidentical transplants for patients with graft failure after the first allograftPiyanuch Kongtim, Maria Bittencourt, Samer A Srour, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.
Pageof 27

Showing results (81-90 of 262) with videos related to

Sort By:
Pageof 27
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of TreatmentManuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Blood|June 21, 2008
The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasmsConstantine S Tam, Roberto M Nussenzveig, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
American Journal of Hematology|April 23, 2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphomaChitra Hosing, Rima M Saliba, Sheena Ahlawat, et al.
American Journal of Hematology|July 1, 2020
Haploidentical transplants for patients with graft failure after the first allograftPiyanuch Kongtim, Maria Bittencourt, Samer A Srour, et al.
Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.
Pageof 27